Ixico sees clear path to become major pharma services provider
A 'wide and deep' portfolio of data around neurological diseases is very valuable
Company
IXICO PLC
LON:IXI
IXICO is no ordinary Imaging Contract Research Organisation (iCRO). By unlocking valuable insights into drug safety and efficacy, IXICO has built a highly respected global reputation and a 20-year track record as an end-to-end iCRO. IXICO addresses the complex biomarker challenges associated with neurodegenerative conditions, expertly managing and analysing neuroimaging clinical trials in areas such as Alzheimer’s, Parkinson’s, Huntington's and other rare diseases.
263 stories · page 7 of 14
Archive
Proactive snapshot: Eland Oil & Gas, Ixico, Rockfire Resources
A look at some of the top stories from the Proactive newswire on Tuesday
Ixico beats forecasts on strong demand for brain scan software
Revenue increased year-on-year by 40% to £7.6mln, up from £5.4mln in 2018, while orders at the year-end were £15.9mln
IXICO makes two boardroom changes
Going forward, IXICO will have two executive directors and three non-execs
IXICO says performance "materially ahead of expectations"; will break even in second-half
The group has benefited from accelerated by new and expanded contracts, the deployment of a newly-developed algorithms and faster turnaround times in trial initiation
IXICO says it is on track to meet market expectations as it gives an upbeat assessment of prospects
The company’s technology is used to interpret brain scans and is deployed by drug developers to aid with clinical trial
Archive
Proactive news snapshot: Hurricane Energy PLC , Allergy Therapeutics, Polarean Imaging, Benchmark Holdings …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Attis surges after increasing production levels
A look at the day's major movers, including GCM, Alexander Mining, Jubilee Metals, McBride, Sosandar and Tekcapital
Investments and investor services
FTSE 100 closes lower again as European shares slide as mood sours
Footsie closed on Thursday nearly 21 points lower at 7,509.
Archive
Informa strikes TMT swap deal with IHS Markit
A look at some of the top risers and fallers on the London Stock Exchange on Wednesday, including 21st Century Technology, Thruvision, Hargreaves Services, Management Resource Solutions, SafeCharge International, IG Group, Pets at Home, and
Archive
Proactive news snapshot: Sound Energy, Bushveld Minerals, Motif Bio, IXICO …
A glance at some of the day's highlights from the Proactive Investors newswire
IXICO swings to profit in latest half-year
The neuroscience-focused data analytics group reported a pre-tax profit on ordinary activities of £106,000, up from a £514,000 loss in the prior year
Archive
FTSE 100 closes slightly ahead but Wall Street shares slide
The Footsie closed out at 7,334 - up around five points, while mid-cap index was firmly lower- down 129 points at 19,307
Archive
Inflation figures to lead macro news on Wednesday, Royal Mail braces for full year figures
Economists are expecting the consumer price index to be well below the recent growth in average earnings at around 1.8% year-on-year in April
Archive
Proactive news snapshot: Feedback, BigDish, Scancell, Sirius Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Sirius Minerals blooms after signing agribusiness deal
A look at the day's major movers, including Image Scan, Water Intelligence, Laura Ashley, Gulf Marine, Synectics and Synnovia
IXICO reiterates full year guidance as revenues rise over 20% in first half
The neuroscience-focused data analytics group said revenues for the six months were expected to be £3.43mln, 22% higher than a year ago
Archive
FTSE 100 ends lower as US stocks retreat after mixed tech earnings
The FTSE 100 index closed 37.62 points, or 0.5% lower at 7,434.13, albeit above the session low of 7,405.99 as US stocks continued to post big falls on Thursday
Archive
Proactive news snapshot: Westminster Group, Tekcapital, Shield Therapeutics …
A glance at some of the day's highlights from the Proactive Investors newswire